Literature DB >> 28346580

Searching for Neurodegeneration in the Blood of Patients With Alzheimer Disease.

Douglas Galasko1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28346580      PMCID: PMC5957497          DOI: 10.1001/jamaneurol.2017.0010

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  7 in total

Review 1.  Fluid biomarkers for mild traumatic brain injury and related conditions.

Authors:  Henrik Zetterberg; Kaj Blennow
Journal:  Nat Rev Neurol       Date:  2016-09-16       Impact factor: 42.937

2.  Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases.

Authors:  Mehtap Bacioglu; Luis F Maia; Oliver Preische; Juliane Schelle; Anja Apel; Stephan A Kaeser; Manuel Schweighauser; Timo Eninger; Marius Lambert; Andrea Pilotto; Derya R Shimshek; Ulf Neumann; Philipp J Kahle; Matthias Staufenbiel; Manuela Neumann; Walter Maetzler; Jens Kuhle; Mathias Jucker
Journal:  Neuron       Date:  2016-06-09       Impact factor: 17.173

3.  Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology.

Authors:  Martina Sattlecker; Steven J Kiddle; Stephen Newhouse; Petroula Proitsi; Sally Nelson; Stephen Williams; Caroline Johnston; Richard Killick; Andrew Simmons; Eric Westman; Angela Hodges; Hilkka Soininen; Iwona Kłoszewska; Patrizia Mecocci; Magda Tsolaki; Bruno Vellas; Simon Lovestone; Richard J B Dobson
Journal:  Alzheimers Dement       Date:  2014-04-25       Impact factor: 21.566

4.  Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.

Authors:  Johanna Gaiottino; Niklas Norgren; Ruth Dobson; Joanne Topping; Ahuva Nissim; Andrea Malaspina; Jonathan P Bestwick; Andreas U Monsch; Axel Regeniter; Raija L Lindberg; Ludwig Kappos; David Leppert; Axel Petzold; Gavin Giovannoni; Jens Kuhle
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

5.  Plasma β-amyloid in Alzheimer's disease and vascular disease.

Authors:  Shorena Janelidze; Erik Stomrud; Sebastian Palmqvist; Henrik Zetterberg; Danielle van Westen; Andreas Jeromin; Linan Song; David Hanlon; Cristina A Tan Hehir; David Baker; Kaj Blennow; Oskar Hansson
Journal:  Sci Rep       Date:  2016-05-31       Impact factor: 4.379

6.  Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.

Authors:  Niklas Mattsson; Ulf Andreasson; Henrik Zetterberg; Kaj Blennow
Journal:  JAMA Neurol       Date:  2017-05-01       Impact factor: 18.302

7.  Plasma neurofilament light chain predicts progression in progressive supranuclear palsy.

Authors:  Julio C Rojas; Anna Karydas; Jee Bang; Richard M Tsai; Kaj Blennow; Victor Liman; Joel H Kramer; Howard Rosen; Bruce L Miller; Henrik Zetterberg; Adam L Boxer
Journal:  Ann Clin Transl Neurol       Date:  2016-02-01       Impact factor: 4.511

  7 in total
  1 in total

1.  Can brain impermeable BACE1 inhibitors serve as anti-CAA medicine?

Authors:  Jian-Ming Li; Li-Ling Huang; Fei Liu; Bei-Sha Tang; Xiao-Xin Yan
Journal:  BMC Neurol       Date:  2017-08-25       Impact factor: 2.474

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.